Beta-hCG (β-hCG) Test

The Beta-hCG (β-hCG) Test at Pamel Laboratories measures the level of human chorionic gonadotropin (hCG) in the blood. hCG is a hormone produced primarily during pregnancy by the developing placenta, and it is one of the earliest markers for confirming pregnancy. In addition to its role in pregnancy detection, β-hCG is also used as a tumor marker in certain cancers, including testicular, ovarian, and gestational trophoblastic diseases.

This test provides quantitative results, allowing doctors to monitor the progression of pregnancy, detect ectopic pregnancies, and assess hCG-producing tumors.

What the Test Measures:

• The concentration of beta subunit of hCG hormone in the blood

• Used to confirm pregnancy and monitor specific tumor conditions

Purpose of the Test:

• Confirm and monitor early pregnancy

• Estimate gestational age and monitor pregnancy progression

• Detect ectopic or abnormal pregnancies

• Monitor recovery after miscarriage

• Evaluate or monitor:

  • Germ cell tumors (testicular or ovarian)

  • Choriocarcinoma and other trophoblastic tumors

  • Response to cancer treatment

Sample Type: Blood sample (serum or plasma)
Fasting Required: No
Turnaround Time: 1–2 working days

Interpretation Guide:

• Elevated β-hCG in females: Indicates pregnancy or, in rare cases, tumor presence

• Elevated β-hCG in males: May suggest testicular cancer or germ cell tumors

Levels are interpreted based on gestational age or clinical history